May 26, 2020
Pharmactive: Carob Extract Shows Weight Management, Syndrome X Benefits
May 29, 2019
New Research Examines Blueberries' Effect On Cardiometabolic Health In Adults With Metabolic Syndrome
Mar 12, 2019
Lipocine's LPCN 1144 for NASH Demonstrates Substantial Fatty Liver Resolution and Meaningful Liver Fat Reduction in NAFLD Population
Mar 08, 2019
TaiwanJ Pharmaceuticals Obtained US$26M Deal for Licensing and Co-Development Contract with Newsoara Biopharma on JKB-122 Asian Rights
Sep 05, 2018
Prometic to host Key Opinion Leader meeting on PBI-4050, a novel treatment for Alström Syndrome and promising therapeutic for non alcoholic steatohepatitis (NASH)
Jun 25, 2018
Type 2 Diabetes Risk in Asian Indian Immigrants in U.S. Impacted by Adopted Lifestyle Habits
Jun 22, 2018
Prometic Presents New Data on NASH Drug Candidate PBI-4547
Jun 01, 2018
Nitto Pharma Research: Clinical Applications of Postbiotics in the Treatment of Helicobacter Infections
May 15, 2018
GOLO, LLC Open Label Study Shows Impressive Results in Patients With Type 2 Diabetes
May 01, 2018
Restore Health Announces Results of Program Helping to Reverse Chronic Disease High-Risk Factors in Employer Population
May 01, 2018
Naturally Slim® Optimized to Drive Bigger Health Impact for Millions of Americans
Apr 27, 2018
Nitto Pharma Research: Advances in Probiotics Research for Healthcare
Apr 12, 2018
Prometic Presents New PBI-4050 Clinical Data From Ongoing Alström Syndrome Phase 2 Trial
Apr 03, 2018
New Study: Pecans Improved Certain Markers Related To Cardiometabolic Health In Overweight And Obese Adults
Mar 16, 2018
Developments in the Obesity Treatment Market
Mar 07, 2018
Gencia, LLC Will Present Preclinical Results in the DIAMOND Mice Supporting the Therapeutic Potential of Its Lead Mitochondrial Therapeutic, GEN-3026, to Treat NASH at the International Liver Congress(TM), Paris, France, April 11-15 2018
Jan 24, 2018
Livongo Launches Hypertension
Jan 23, 2018
Targeted Workplace Coaching Programs Provide Choices to Employers
Jan 09, 2018
NIH Awards Longeveron Cutting-Edge Research Grant to Fight 'Metabolic Syndrome' of Obesity, High Blood Pressure, Unhealthy Cholesterol and More through Regenerative Medicine
Dec 14, 2017
reMYND Enters Into License Agreement to Further Develop Novel Treatments Improving Beta-cell Health and Insulin Signalling With Novo Nordisk